123 related articles for article (PubMed ID: 20677319)
1. Synthesis and biological activities of azalamellarins.
Boonya-Udtayan S; Yotapan N; Woo C; Bruns CJ; Ruchirawat S; Thasana N
Chem Asian J; 2010 Sep; 5(9):2113-23. PubMed ID: 20677319
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of new geiparvarin derivatives.
Chimichi S; Boccalini M; Salvador A; Dall'Acqua F; Basso G; Viola G
ChemMedChem; 2009 May; 4(5):769-79. PubMed ID: 19322800
[TBL] [Abstract][Full Text] [Related]
3. Novel synthesis, cytotoxic evaluation, and structure-activity relationship studies of a series of alpha-alkylidene-gamma-lactones and lactams.
Janecki T; Błaszczyk E; Studzian K; Janecka A; Krajewska U; Rózalski M
J Med Chem; 2005 May; 48(10):3516-21. PubMed ID: 15887960
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of aristolactam analogues and evaluation of their antitumor activity.
Choi YL; Kim JK; Choi SU; Min YK; Bae MA; Kim BT; Heo JN
Bioorg Med Chem Lett; 2009 Jun; 19(11):3036-40. PubMed ID: 19394218
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of a series of novel delta-lactam-based histone deacetylase inhibitors.
Kim HM; Ryu DK; Choi Y; Park BW; Lee K; Han SB; Lee CW; Kang MR; Kang JS; Boovanahalli SK; Park SK; Han JW; Chun TG; Lee HY; Nam KY; Choi EH; Han G
J Med Chem; 2007 May; 50(11):2737-41. PubMed ID: 17477518
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiproliferative activity of some steroidal lactams.
Huang Y; Cui J; Chen S; Gan C; Zhou A
Steroids; 2011 Nov; 76(12):1346-50. PubMed ID: 21767556
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicities and structure-activity relationships of natural and unnatural lamellarins toward cancer cell lines.
Chittchang M; Batsomboon P; Ruchirawat S; Ploypradith P
ChemMedChem; 2009 Mar; 4(3):457-65. PubMed ID: 19152364
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic activities of 4,5-diarylisoxazoles.
Sun CM; Lin LG; Yu HJ; Cheng CY; Tsai YC; Chu CW; Din YH; Chau YP; Don MJ
Bioorg Med Chem Lett; 2007 Feb; 17(4):1078-81. PubMed ID: 17127061
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.
Nagarajan M; Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M
J Med Chem; 2003 Dec; 46(26):5712-24. PubMed ID: 14667224
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.
Liu T; Dong X; Xue N; Wu R; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Sep; 17(17):6279-85. PubMed ID: 19665898
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
Gangjee A; Adair OO; Queener SF
J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of curcumin analogues.
Fuchs JR; Pandit B; Bhasin D; Etter JP; Regan N; Abdelhamid D; Li C; Lin J; Li PK
Bioorg Med Chem Lett; 2009 Apr; 19(7):2065-9. PubMed ID: 19249204
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel indolyl-1,2,4-triazoles as potent and selective anticancer agents.
Kumar D; Narayanam MK; Chang KH; Shah K
Chem Biol Drug Des; 2011 Mar; 77(3):182-8. PubMed ID: 21251232
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
Congiu C; Cocco MT; Onnis V
Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
[TBL] [Abstract][Full Text] [Related]
17. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.
Xie F; Zhao H; Zhao L; Lou L; Hu Y
Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425
[TBL] [Abstract][Full Text] [Related]
19. Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents.
Devegowda VN; Kim JH; Han KC; Yang EG; Choo H; Pae AN; Nam G; Choi KI
Bioorg Med Chem Lett; 2010 Mar; 20(5):1630-3. PubMed ID: 20138760
[TBL] [Abstract][Full Text] [Related]
20. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
